These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23808102)

  • 1. The moral from Sorrell: educate, don't legislate.
    Gooch GR; Rohack JJ; Finley M
    Health Matrix Clevel; 2013; 23(1):237-77. PubMed ID: 23808102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription data mining, medical privacy and the First Amendment: the U.S. Supreme Court in Sorrell v. IMS health Inc.
    Boumil MM; Dunn K; Ryan N; Clearwater K
    Ann Health Law; 2012; 21(2):447-91, 4 p preceding i. PubMed ID: 22606922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical analysis of Sorrell v. IMS Health, Inc.: Pandora's box at best.
    Bibet-Kalinyak I
    Food Drug Law J; 2012; 67(2):191-241, ii. PubMed ID: 24620419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorrell v. IMS Health: issues and opportunities for informaticians.
    Petersen C; Demuro P; Goodman KW; Kaplan B
    J Am Med Inform Assoc; 2013 Jan; 20(1):35-7. PubMed ID: 23104048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictions on the use of prescribing data for drug promotion.
    Mello MM; Messing NA
    N Engl J Med; 2011 Sep; 365(13):1248-54. PubMed ID: 21812664
    [No Abstract]   [Full Text] [Related]  

  • 6. Sorrell v. IMS Health Inc.: data mining of pharmacy records and drug marketing as free speech.
    Cartwright-Smith L; Lopez N
    Public Health Rep; 2013; 128(1):64-6. PubMed ID: 23277662
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescriptions, privacy, and the First Amendment.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical detailing is not for everyone: side effects may include sub-optimal prescribing decisions, compromised patient health, and increased prescription drug spending.
    Hoffman MN
    J Leg Med; 2012 Jul; 33(3):381-97. PubMed ID: 22991956
    [No Abstract]   [Full Text] [Related]  

  • 9. Restrictions on use of prescribing data for drug promotion.
    Carmel PW
    N Engl J Med; 2012 Jan; 366(3):279. PubMed ID: 22256818
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher First Amendment hurdles for public health regulation.
    Outterson K
    N Engl J Med; 2011 Aug; 365(7):e13. PubMed ID: 21812665
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescriptions, privacy, and the First Amendment.
    Jacobsen RB
    N Engl J Med; 2011 Aug; 365(5):473-4. PubMed ID: 21812697
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of off-label marketing regulations in the post-Sorrell era.
    Iraggi J
    Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription data mining and the protection of patients' interests.
    Orentlicher D
    J Law Med Ethics; 2010; 38(1):74-84. PubMed ID: 20446986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescriptions, privacy, and the first amendment.
    Gewurz AT
    N Engl J Med; 2011 Aug; 365(5):474. PubMed ID: 21812695
    [No Abstract]   [Full Text] [Related]  

  • 15. Technology-enabled academic detailing: computer-mediated education between pharmacists and physicians for evidence-based prescribing.
    Ho K; Nguyen A; Jarvis-Selinger S; Novak Lauscher H; Cressman C; Zibrik L
    Int J Med Inform; 2013 Sep; 82(9):762-71. PubMed ID: 23770028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selling health data: de-identification, privacy, and speech.
    Kaplan B
    Camb Q Healthc Ethics; 2015 Jul; 24(3):256-71. PubMed ID: 26059952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.
    Larkin I; Ang D; Steinhart J; Chao M; Patterson M; Sah S; Wu T; Schoenbaum M; Hutchins D; Brennan T; Loewenstein G
    JAMA; 2017 May; 317(17):1785-1795. PubMed ID: 28464141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The commercial speech doctrine in health regulation: the clash between the public interest in a robust First Amendment and the public interest in effective protection from harm.
    Orentlicher D
    Am J Law Med; 2011; 37(2-3):299-314. PubMed ID: 21847883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.